Vaccines, blood, antisera, toxins and cultures in   Ireland

Exports In 2023, Ireland exported $51.3B in Vaccines, blood, antisera, toxins and cultures, making it the 2nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 1st most exported product in Ireland. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Ireland are: United States ($18.3B), Belgium ($7.57B), China ($6.51B), Germany ($4.24B), and Switzerland ($3.19B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Ireland between 2022 and 2023 were China ($1.71B), United States ($1.2B), and France ($893M).

Imports In 2023, Ireland imported $6.95B in Vaccines, blood, antisera, toxins and cultures, becoming the 11th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 3rd most imported product in Ireland. Ireland imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($3.06B), Germany ($725M), Spain ($575M), France ($439M), and Netherlands ($408M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Ireland between 2022 and 2023 were United States ($512M), Singapore ($190M), and Germany ($130M).